Patent application number | Description | Published |
20090022828 | METHODS AND COMPOSITIONS FOR INHIBITING ANGIOTENSIN CONVERTING AND CHYMASE ENZYMES - The present invention relates to medicinal products, as well as to health and wellness food products, and particularly to a medicinal product or a health and wellness food product for inhibiting Angiotensin Converting Enzyme and Chymase enzyme pathways. | 01-22-2009 |
20090022830 | MORINDA CITRIFOLIA LEAF EXTRACT COMPOSITIONS AND METHODS OF OBTAINING THE SAME - Methods and compositions relating to leaf extracts obtained from removing liquids from relatively dry | 01-22-2009 |
20090053336 | Method and Formulations for Treating Candidiasis Using Morinda Citrifolia - The present invention features a novel use of processed ingredients from the Indian mulberry plant, and particularly a novel use of one or more processed | 02-26-2009 |
20090053341 | Preventative and Treatment Effects of Morinda Citrifolia as an Aromatase Inhibitor - The present invention is directed to methods of inhibiting Aromatase or Aromatase enzymes that function to convert androgens to estrogens, inhibiting receptors from binding with estrogen, and reducing and/or regulating estrogen production, as well as reducing the amount of estrogen produced within the body and regulating such production. The present invention methods and compositions effectively function to treat estrogen-dependent cancers, and particularly inhibit, destroy, and reverse the effects of estrogen-dependent cancerous tumors through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed | 02-26-2009 |
20110206786 | Acai and Iridoid Based Formulations - Embodiments of the invention relate to fortified food and dietary supplement products, which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relate to the administration of products enhanced with Acai and iridoids. | 08-25-2011 |
20110206787 | Morinda Citrifolia and Iridoid Based Formulations - Embodiments of the invention relate to fortified food and dietary supplement products which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced with | 08-25-2011 |
20110217394 | Iridoid Based Formulations - Embodiments of the invention relate to fortified food and dietary supplement products which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced with plant products and iridoids. | 09-08-2011 |
20120021079 | Garcinia Mangostana L. and Iridoid Based Formulations - Embodiments of the invention relate to fortified food and dietary supplement products, which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relate to the administration of products enhanced with | 01-26-2012 |
20120328720 | Iridoid Based Formulations - Fortified food and dietary supplement products may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced with plant products and iridoids. A study was performed to evaluate the iridoid content, as well as the in vitro and in vivo bioactivities, of a beverage containing noni fruit, Cornelian cherries, and olive leaf extract. The major iridoids present were identified as asperulosidic acid, deacetylasperulosidic acid, oleuropein, morroniside, loganic acid, and loganin In the 2,2-Diphenylpicrylhydrazyl (DPPH) radical scavenging assay, remarkably high in vitro antioxidant activity was observed, with an IC | 12-27-2012 |
20150086655 | Morinda Citrifolia Juice Formulations Comprising Iridoids - Embodiments of the invention relate to fortified food and dietary supplement products which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced with plant products and iridoids. A study was performed to evaluate the iridoid content, as well as the in vitro and in vivo bioactivities, of a beverage containing noni fruit, Cornelian cherries, and olive leaf extract. The major iridoids present were identified as asperulosidic acid, deacetylasperulosidic acid, oleuropein, morroniside, loganic acid, and loganin In the 2,2-Diphenylpicrylhydrazyl (DPPH) radical scavenging assay, remarkably high in vitro antioxidant activity was observed, with an IC | 03-26-2015 |